RenovoRX Expands Indications for Use for Dual-Balloon Catheter
RenovoRx has been cleared by the FDA to expand the indications for use for its adjustable dual-balloon infusion catheter to include the delivery of chemotherapeutics.
The RenovoCath device isolates segments of the peripheral vasculature, allowing physicians to deliver drugs in a more targeted fashion. The two balloons can be inflated independently, and the distance between them can be adjusted to isolate the desired treatment target, allowing for more targeted therapy.
The device has been used to treat great pelvic vein congestion, adenocarcinoma of the pancreas, liver cancer, and other diseases.
The new clearance expands the catheter's marketability for use with chemotherapeutics and potentially increases the number of diseases the device may be used to treat.